We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-9%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$190M
AUM Growth
-$46.3M
Cap. Flow
-$23.9M
Cap. Flow %
-12.58%
Top 10 Hldgs %
46.87%
Holding
49
New
14
Increased
5
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$7.1M
2
WAT icon
Waters Corp
WAT
+$5.12M
3
A icon
Agilent Technologies
A
+$4.79M
4
ABBV icon
AbbVie
ABBV
+$4.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.91M

Sector Composition

Rank Sector Weight
1 Healthcare 85.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$18M 9.48%
200,000
-100,000
-33% -$9.69M
LLY icon
2
Eli Lilly
LLY
$1.06T
$11.6M 6.1%
15,000
+500
+3% +$414K
BSX icon
3
Boston Scientific
BSX
$71.5B
$9.82M 5.17%
110,000
+5,000
+5% +$440K
MCK icon
4
McKesson
MCK
$101B
$8.55M 4.5%
15,000
-5,000
-25% -$2.8M
ISRG icon
5
PUT
Intuitive Surgical
ISRG
$134B
$7.83M 4.12%
+15,000
New +$7.81M
SYK icon
6
Stryker
SYK
$130B
$7.2M 3.79%
20,000
-7,000
-26% -$2.59M
THC icon
7
Tenet Healthcare
THC
$21.1B
$6.94M 3.66%
55,000
-10,000
-15% -$1.49M
UHS icon
8
Universal Health Services
UHS
$10.5B
$6.73M 3.54%
37,500
-7,500
-17% -$1.53M
UNH icon
9
UnitedHealth
UNH
$370B
$6.32M 3.33%
+12,500
New +$7.1M
NVO
10
Novo Nordisk
NVO
$209B
$6.02M 3.17%
70,000
-20,000
-22% -$2.16M
HCA icon
11
HCA Healthcare
HCA
$89.5B
$6M 3.16%
20,000
CAH icon
12
Cardinal Health
CAH
$55.4B
$5.91M 3.11%
50,000
+5,000
+11% +$584K
DHR icon
13
Danaher
DHR
$144B
$5.74M 3.02%
25,000
-5,000
-17% -$1.23M
ABT icon
14
Abbott
ABT
$187B
$5.66M 2.98%
50,000
-10,000
-17% -$1.16M
COR icon
15
Cencora
COR
$61.2B
$5.62M 2.96%
25,000
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$126B
$5.24M 2.76%
13,000
+3,000
+30% +$1.39M
WAT icon
17
Waters Corp
WAT
$39.9B
$5.19M 2.74%
+14,000
New +$5.12M
HUM icon
18
Humana
HUM
$46.2B
$5.07M 2.67%
20,000
+10,000
+100% +$2.68M
A icon
19
Agilent Technologies
A
$41.2B
$4.7M 2.48%
+35,000
New +$4.79M
ABBV icon
20
AbbVie
ABBV
$435B
$4.44M 2.34%
+25,000
New +$4.6M
SGRY icon
21
Surgery Partners
SGRY
$2.03B
$4.23M 2.23%
200,000
-30,000
-13% -$787K
AVTR icon
22
Avantor
AVTR
$9.19B
$4.21M 2.22%
200,000
-50,000
-20% -$1.12M
EHC icon
23
Encompass Health
EHC
$12.4B
$4.16M 2.19%
45,000
-5,000
-10% -$491K
BMY icon
24
Bristol-Myers Squibb
BMY
$132B
$3.96M 2.08%
+70,000
New +$3.91M
EW icon
25
Edwards Lifesciences
EW
$51.7B
$3.7M 1.95%
+50,000
New +$3.5M

Similar funds

Sivik Global Healthcare's Q4 2024 Portfolio in Review

As of Q4 2024, Sivik Global Healthcare held 49 positions worth $190M, down 20% from $236M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sivik Global Healthcare withdrew a net $23.9M in Q4 2024, closing 11 positions and reducing 17 holdings. Its most notable exit was Intuitive Surgical, an estimated $9.11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in UnitedHealth worth $6.32M.

  • Sivik Global Healthcare's largest Q4 2024 buy was UnitedHealth: 12,500 shares worth $6.32M.
  • Sivik Global Healthcare added most to Humana in Q4 2024, an estimated $2.68M increase.
  • Sivik Global Healthcare's biggest Q4 2024 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $9.69M.
  • Sivik Global Healthcare fully exited Intuitive Surgical in Q4 2024, selling an estimated $9.11M.
  • Sivik Global Healthcare's ten largest holdings make up 47% of its $190M portfolio in Q4 2024.
  • Sivik Global Healthcare opened 14 new positions and closed 11 in Q4 2024.
  • Sivik Global Healthcare's portfolio value fell 20% quarter-over-quarter to $190M.

Based on Sivik Global Healthcare's 13F filing for Q4 2024, filed 23 Jan 2025.